Charles Silberstein

Insider Reports History

Location
New York, NY
Signature
/s/ Shoshana Shendelman as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles Silberstein:

Company Role Class Num Shares Value Price $ Report Date Ownership
Applied Therapeutics Inc. Chief Financial Officer Common Stock 183,603 $400,053 $2.18 07 Jan 2022 Direct
Applied Therapeutics Inc. Chief Financial Officer Employee Stock Option (Right to Buy) 32,000 07 Jan 2022 Direct

Insider Reports Filed by Charles Silberstein

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APLT Applied Therapeutics Inc. 07 Jan 2022 2 $0 4 Chief Financial Officer 11 Jan 2022, 17:45
APLT Applied Therapeutics Inc. 14 Dec 2021 1 $0 4/A Chief Financial Officer 11 Jan 2022, 17:43
APLT Applied Therapeutics Inc. 08 Jun 2021 1 -$108,107 4 Chief Financial Officer 10 Jun 2021, 21:01